✦ LIBER ✦

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

✍ Scribed by Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Shunsuke Kondo; Masafumi Ikeda; Junji Furuse; Ohkawa Shinichi; Kohei Nakachi; Shuichi Mitsunaga; Yasushi Kojima; Eiichiro Suzuki; Makoto Ueno; Tomohiro Yamaguchi

Book ID: 113028023
Publisher: Springer
Year: 2011
Tongue: English
Weight: 226 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1786-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3544 POSTER Phase I study of gemcitabine

3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.

✍ C. Morizane; T. Okusaka; J. Furuse; H. Ishii; H. Ueno; M. Ikeda; T. Ogura; K. Na 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Phase II study of a fixed dose-rate infu

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

✍ J. Feliu; P. Borrega; A. León; L. López-Gómez; M. López; J. Castro; C. Belda-Ini 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 287 KB

A phase 1 study of fixed dose rate gemci

A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer

✍ Weijing Sun; Maureen R. Hewitt; Marry R. Theobald; Diane Hershock; Daniel G. Hal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND. The combination of a fixed dose rate (FDR) infusion of gemcitabine and irinotecan may have a synergistic effect in the treatment of patients with advanced and metastatic pancreatic and biliary cancer. The current study was conducted to determine the dose‐limiting toxicit

Phase I/II study of combined modality th

Phase I/II study of combined modality therapy in pancreatic cancer with gemcitabine (Gem) and escalating dose radiation therapy (RT)

✍ J.D. Brierley; A.M. Oza; C.S. Wong; J. Ringash; P. Catton; L. Siu; D. Hedley; R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 24 KB

A multicenter phase II study of gemcitab

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

✍ Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB

Phase I/II trial of doxorubicin and fixe

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

✍ López-Pousa, A; Losa, R; Martín, J; Maurel, J; Fra, J; Sierra, M; Casado, A; Gar 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB